Hypocomplementemia during tocilizumab treatment: Long-term follow-up results

Hypocomplementemia has been reported in patients with rheumatoid arthritis treated with tocilizumab (TCZ), but its long-term consequences are unknown. We assessed the long-term outcome of patients treated with TCZ who developed hypocomplementemia regarding serious bacterial infections or autoimmune...

Descripción completa

Detalles Bibliográficos
Autores principales: Bieber, Amir, Markovits, Doron, Toledano, Kohava, Tavor, Yonit, Mader, Reuven, Balbir-Gurman, Alexandra, Braun-Moscovici, Yolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
6900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276208/
https://www.ncbi.nlm.nih.gov/pubmed/35713462
http://dx.doi.org/10.1097/MD.0000000000029528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276208/
https://www.ncbi.nlm.nih.gov/pubmed/35713462
http://dx.doi.org/10.1097/MD.0000000000029528

Ejemplares similares